1. Home
  2. VKTX vs HCC Comparison

VKTX vs HCC Comparison

Compare VKTX & HCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • HCC
  • Stock Information
  • Founded
  • VKTX 2012
  • HCC 2015
  • Country
  • VKTX United States
  • HCC United States
  • Employees
  • VKTX N/A
  • HCC N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • HCC Coal Mining
  • Sector
  • VKTX Health Care
  • HCC Energy
  • Exchange
  • VKTX Nasdaq
  • HCC Nasdaq
  • Market Cap
  • VKTX 3.8B
  • HCC 3.3B
  • IPO Year
  • VKTX 2015
  • HCC 2017
  • Fundamental
  • Price
  • VKTX $34.40
  • HCC $75.17
  • Analyst Decision
  • VKTX Strong Buy
  • HCC Buy
  • Analyst Count
  • VKTX 14
  • HCC 6
  • Target Price
  • VKTX $87.07
  • HCC $72.20
  • AVG Volume (30 Days)
  • VKTX 4.3M
  • HCC 928.7K
  • Earning Date
  • VKTX 10-22-2025
  • HCC 11-05-2025
  • Dividend Yield
  • VKTX N/A
  • HCC 0.43%
  • EPS Growth
  • VKTX N/A
  • HCC N/A
  • EPS
  • VKTX N/A
  • HCC 0.67
  • Revenue
  • VKTX N/A
  • HCC $1,224,320,000.00
  • Revenue This Year
  • VKTX N/A
  • HCC N/A
  • Revenue Next Year
  • VKTX N/A
  • HCC $42.35
  • P/E Ratio
  • VKTX N/A
  • HCC $112.26
  • Revenue Growth
  • VKTX N/A
  • HCC N/A
  • 52 Week Low
  • VKTX $18.92
  • HCC $38.00
  • 52 Week High
  • VKTX $56.25
  • HCC $85.86
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 44.88
  • HCC 54.38
  • Support Level
  • VKTX $34.67
  • HCC $76.76
  • Resistance Level
  • VKTX $43.15
  • HCC $85.86
  • Average True Range (ATR)
  • VKTX 2.70
  • HCC 3.74
  • MACD
  • VKTX -0.69
  • HCC -0.61
  • Stochastic Oscillator
  • VKTX 13.85
  • HCC 49.98

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About HCC Warrior Met Coal Inc.

Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.

Share on Social Networks: